We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Nabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Post Liver Transplantation (Nabi-HB-SC)

This study has been withdrawn prior to enrollment.
(New sponsor's existing product under evaluation for this indication)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00800787
First Posted: December 2, 2008
Last Update Posted: January 18, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Biotest Pharmaceuticals Corporation
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: September 2010
  Estimated Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)

To Top